These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 38486847)

  • 21. Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 2.
    Deleruyelle LJ
    Int J Pharm Compd; 2016; 20(6):447-454. PubMed ID: 28339382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transdermal delivery of bioidentical estrogen in menopausal hormone therapy: a clinical review.
    Files J; Kling JM
    Expert Opin Drug Deliv; 2020 Apr; 17(4):543-549. PubMed ID: 31795776
    [No Abstract]   [Full Text] [Related]  

  • 23. Efficacy and tolerability of compounded bioidentical hormone replacement therapy.
    Vigesaa KA; Downhour NP; Chui MA; Cappellini L; Musil JD; McCallian DJ
    Int J Pharm Compd; 2004; 8(4):313-9. PubMed ID: 23924704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Compounded bioidentical hormone therapy: identifying use trends and knowledge gaps among US women.
    Pinkerton JV; Santoro N
    Menopause; 2015 Sep; 22(9):926-36. PubMed ID: 25692877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Compounded Bioidentical Hormones: Myths and Realities.
    Santoro N; Liss J
    Clin Obstet Gynecol; 2021 Dec; 64(4):793-802. PubMed ID: 34482337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effectiveness of sublingual and topical compounded bioidentical hormone replacement therapy in postmenopausal women: an observational cohort study.
    Ruiz AD; Daniels KR
    Int J Pharm Compd; 2014; 18(1):70-7. PubMed ID: 24881343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Compounded or confused? Bioidentical hormones and menopausal health.
    Huntley AL
    Menopause Int; 2011 Mar; 17(1):16-8. PubMed ID: 21427420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 3.
    Deleruyelle LJ
    Int J Pharm Compd; 2017; 21(1):6-16. PubMed ID: 28346192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Custom-compounded bioidentical hormone therapy: why so popular despite potential harm? The case against routine use.
    L'Hermite M
    Climacteric; 2017 Jun; 20(3):205-211. PubMed ID: 28509626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioidentical hormone therapy: An assessment of provider knowledge.
    Files JA; Kransdorf LN; Ko M; Kling JM; David PS; Pruthi S; Sood R; Creedon D; Chang YH; Mayer AP
    Maturitas; 2016 Dec; 94():46-51. PubMed ID: 27823744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bioidentical hormone therapy in menopause: relevance in dermatology.
    Borda LJ; Wong LL; Tosti A
    Dermatol Online J; 2019 Jan; 25(1):. PubMed ID: 30710894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioidentical hormones for menopausal therapy.
    Sites CK
    Womens Health (Lond); 2008 Mar; 4(2):163-71. PubMed ID: 19072518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
    Stephenson K; Neuenschwander PF; Kurdowska AK
    Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Menopausal Symptom Relief and Side Effects Experienced by Women Using Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 1.
    Deleruyelle LJ
    Int J Pharm Compd; 2016; 20(5):359-364. PubMed ID: 28339370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased Incidence of Endometrial Cancer Following the Women's Health Initiative: An Assessment of Risk Factors.
    Constantine GD; Kessler G; Graham S; Goldstein SR
    J Womens Health (Larchmt); 2019 Feb; 28(2):237-243. PubMed ID: 30484734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Promotion and marketing of bioidentical hormone therapy on the internet: a content analysis of websites.
    Yuksel N; Treseng L; Malik B; Ogbogu U
    Menopause; 2017 Oct; 24(10):1129-1135. PubMed ID: 28609391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioidentical hormone therapy: a review.
    Boothby LA; Doering PL; Kipersztok S
    Menopause; 2004; 11(3):356-67. PubMed ID: 15167316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bioidentical hormones for menopausal hormone therapy: variation on a theme.
    Fugh-Berman A; Bythrow J
    J Gen Intern Med; 2007 Jul; 22(7):1030-4. PubMed ID: 17549577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioidentical progesterone cream for menopause-related vasomotor symptoms: is it effective?
    Whelan AM; Jurgens TM; Trinacty M
    Ann Pharmacother; 2013 Jan; 47(1):112-6. PubMed ID: 23249728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bioidentical hormone therapy.
    Files JA; Ko MG; Pruthi S
    Mayo Clin Proc; 2011 Jul; 86(7):673-80, quiz 680. PubMed ID: 21531972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.